Literature DB >> 300650

Angio-immunoblastic lymphadenopathy terminating as Hodgkin's disease.

X Yataganas, C Papadimitriou, G Pangalis, D Loukopoulos, P Fessas, N Papacharalampous.   

Abstract

The clinical course of a 33-year-old man with generalized lymphadenopathy bearing all physical, laboratory and histologic characteristics of "angio-immunoblastic lymphadenopathy with dysproteinemia" (AILD) is described. Therapy was without significant benefit and the patient died 22 months after initial diagnosis. At autopsy in addition to the characteristic cellular polymorphism of AILD, numerous Hodgkin's cells and Sternberg-Reed cells were identified in the lymph nodes and spleen. Pleomorphic cellular infiltrates containing an increased number of immunoblasts and some giant cells were found also in the portal spaces of the liver. The evolution of Hodgkin's disease (H.D.) from AILD suggests that the latter may have represented a reaction to the agent which causes H.D..

Entities:  

Mesh:

Year:  1977        PMID: 300650     DOI: 10.1002/1097-0142(197705)39:5<2183::aid-cncr2820390535>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Angioimmunoblastic lymphadenopathy. Fine structure of the lymph nodes by correction of light and electron microscopical findings.

Authors:  U Schnaidt; J Thiele; A Georgii
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

2.  Diagnostic impact of molecular lineage analysis on paraffin-embedded tissue in hematolymphoid neoplasia reclassified by current WHO criteria.

Authors:  Leonard Hwan Cheong Tan; Lily-Lily Chiu; Evelyn Siew Chuan Koay
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

3.  Histological, immunohistological and autopsy findings in lymphogranulomatosis X (including angio-immunoblastic lymphadenopathy).

Authors:  H Knecht; E W Schwarze; K Lennert
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

4.  Malignant progression of angioimmunoblastic lymphadenopathy.

Authors:  M Bamberg; K Donhuijsen; P G Höher; H Holfeld; D K Hossfeld
Journal:  J Cancer Res Clin Oncol       Date:  1979-04-12       Impact factor: 4.553

5.  Immunopathology of angioimmunoblastic lymphadenopathy.

Authors:  D B Jones; M Castleden; J L Smith; B L Mepham; D H Wright
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.